Members
Perspectives Middle East | Biotech is redefining value creation
Biotech is back in focus, driven by growing private equity investment
As value creation increasingly shifts toward private markets, biotechnology is emerging as a strategic investment theme for investors seeking to diversify their portfolios while bringing greater purpose to their capital allocation.
An analysis of the forces reshaping capital flows, value creation drivers, and investment opportunities across the sector.
Eliott Collin, General Manager, Perspectives Middle East
